Kriti Puthenpurakal, DPM
Foot & Ankle Surgery · Naperville, ILNPI 1710319959
Payments from drug & device makers
Across 37 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$156
- Johnson & Johnson$97
- Merck$91
- Otsuka America Pharmaceutical, Inc.$82
- Orexo US, Inc.$45
- Amgen$40
- plus $288 from 15 others
What the payments were for
- Food & beverage$798100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $156 |
| Johnson & Johnson | 4 | $97 |
| Merck | 6 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Orexo US, Inc. | 2 | $45 |
| Amgen | 3 | $40 |
| Si-bone, Inc. | 1 | $33 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Novo Nordisk | 1 | $22 |
| Shionogi Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Organogenesis Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafix PL PRIME$108
- Stravix$108
- Oasis$108
How this compares
$798 in reported general payments places this provider in the 25th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Naperville
- Brian BurgessNaperville$496K
- Douglas PacaccioRockford$4.3M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.4M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$586K
- Kyle PearsonMorris$208K
- Stephanie OexemanChicago$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.